Thank you, U.S. Embassy Madrid for hosting us at your #IndependenceDay reception. We appreciate your continued partnership as we work towards improving the health and safety of those most vulnerable. #COVID19 #Novavax
Novavax
Pharmaceutical Manufacturing
Gaithersburg, Maryland 68,998 followers
Producing next-generation vaccines with global access for more people.
About us
We’re making a difference in the health of people around the world by producing next generation vaccines that are accessible to more people. We stand strong against infectious diseases and viral threats—our science grounds us, our technology pushes us forward, our commitment inspires us to achieve our hopes. We do this work for the greater health of people everywhere. It’s more than our job. It’s our passion. Our Novavax Social Community Guidelines: https://www.novavax.com/social-media-community-guidelines
- Website
-
www.novavax.com
External link for Novavax
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Gaithersburg, Maryland
- Type
- Public Company
- Founded
- 1987
Locations
-
Primary
700 Quince Orchard Rd
Gaithersburg, Maryland 20878, US
-
Líbalova 2348/1
Chodov, Praha 149 00, CZ
-
Kungsgatan 109
Uppsala, Uppsala County SE-753 18, SE
-
Fraumünsterstrasse 16, 8001
Zurich, CH
Employees at Novavax
-
Andrey Chudny
Senior Information Technology Engineer at NOVAVAX INC
-
Markéta Majerová
Data analyst and research professional
-
Terry Lewis
IT Risk Management, Third Party Risk, & Information Security Leader
-
Jason J. K.
Commercial Expertise and Leadership – Pharmaceuticals, Biologics, Vaccines
Updates
-
Novavax was pleased to participate in the Independence Day reception at the U.S. Embassy in Italy. A special thank you to the Ambassador for hosting leading voices across civil and scientific communities. We thank you for your work on behalf of U.S. businesses and for your role in helping improve health and safety in Europe and in Italy. #COVID19 #Novavax
-
Novavax is pleased to have partnered with the US Embassy Paris to host a policy event entitled "COVID-19 Vaccination in France: Concrete Solutions to Improve Vaccination Coverage for the Most Vulnerable" in Paris, France. The event provided a valuable platform to discuss the continuing threat of COVID-19 to those most vulnerable. Bringing together policy makers, healthcare professionals and other leading stakeholders, discussions focused on ongoing challenges to vaccination in France and concrete solutions to improve understanding and uptake. Thanks to everyone involved for their collaboration and commitment. Together, we continue to work towards improving the health and safety of those most vulnerable. #Vaccination #COVID19 #Novavax #Health #Innovation #Collaboration
-
Today the U.S. Advisory Committee on Immunization Practices recommended use of 2024-2025 Formula for COVID-19 vaccines authorized or approved by the U.S. FDA. Novavax has submitted its application to the U.S. FDA and, if authorized, expects to deliver the COVID-19 option in the U.S. Read the statement at: https://lnkd.in/ehyAU3ps
-
Novavax has filed with the European Medicines Agency (EMA) for a type II variation of its existing Marketing Authorization for its updated COVID-19 vaccine. Read the press release at: https://lnkd.in/dfizvc-2
-
Novavax is attending McKesson's ideaShare in New Orleans, LA this week. Attendees can connect with Lori Kinjorski, Director, Trade and Distribution and Michael Mulvey, Senior Director, National Accounts Retail, at this event dedicated to pushing pharmacy forward.
-
Join us in celebrating #Juneteenth, an important day of freedom and equality in the United States. Equity and inclusion are important parts of our workplace, and our quest to help protect public health.
-
Happy #FathersDay! A special shout out to all the fathers at Novavax who help make our innovative science possible. Hear from Tayo Bewaji, Manufacturing Manager, Jared Lantzy, PMP, Executive Director, Global Regulatory Operations, and Farai Michael Sikipa, Associate Director, Global Digital Planning and Performance Analytics, on what it means to be a Dad and #SuperNova.
-
Novavax has submitted its application to the U.S. FDA for its updated COVID-19 vaccine. If authorized, Novavax expects to be ready to deliver the only protein-based COVID-19 option in the U.S. in September. Read the press release at: https://lnkd.in/esxGEpYk